35 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
-based compensation expense is classified in the consolidated statements of operations and comprehensive loss based on the function to which … greater than one year are classified as non-current assets. Available-for-sale securities are carried at fair value with the unrealized gains and losses
ARS
eht4i0sv78o jo5
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
lkpldf9
18 Apr 23
Preliminary proxy
7:59am
424B4
2n52i4k gbeq8fipo4i
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
r98oxl
19 May 21
Draft registration statement
12:00am